According to Sonoma Pharmaceuticals's latest financial reports the company's total assets are $14.61 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $16.23 M | -13.87% |
2022-03-31 | $18.84 M | 25.74% |
2021-03-31 | $14.98 M | 2.93% |
2020-03-31 | $14.56 M | 0.78% |
2019-03-31 | $14.44 M | -24.77% |
2018-03-31 | $19.2 M | -24.56% |
2017-03-31 | $25.45 M | 84.45% |
2016-03-31 | $13.8 M | -8.27% |
2015-03-31 | $15.04 M | -27.62% |
2014-03-31 | $20.79 M | 65.47% |
2013-03-31 | $12.56 M | 60.31% |
2012-03-31 | $7.83 M | -9.53% |
2011-03-31 | $8.66 M | -15.21% |
2010-03-31 | $10.21 M | 87.59% |
2009-03-31 | $5.44 M | -76.93% |
2008-03-31 | $23.61 M | -12.39% |
2007-03-31 | $26.95 M | 112.39% |
2006-03-31 | $12.68 M | 82.84% |
2005-03-31 | $6.94 M | |
2003-03-31 | $0.96 M | -43.03% |
2002-03-31 | $1.68 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | 13,661.80% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $22.68 M | 55.17% | ๐บ๐ธ USA |